ZOFRAN ODT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zofran Odt, and when can generic versions of Zofran Odt launch?
Zofran Odt is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in ZOFRAN ODT is ondansetron. There are twenty-eight drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the ondansetron profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zofran Odt
A generic version of ZOFRAN ODT was approved as ondansetron by CHARTWELL MOLECULES on December 26th, 2006.
Summary for ZOFRAN ODT
Recent Clinical Trials for ZOFRAN ODT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tanta University | Phase 3 |
Tanta University | Phase 2/Phase 3 |
Emory University | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for ZOFRAN ODT
US Patents and Regulatory Information for ZOFRAN ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-001 | Jan 27, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZOFRAN ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-001 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-001 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-001 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | ZOFRAN ODT | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 020781-002 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZOFRAN ODT
See the table below for patents covering ZOFRAN ODT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Cyprus | 2166 | Freeze-dried composition containing ondansetron | ⤷ Try a Trial |
Japan | S63198623 | MEDICINAL COMPOSITION | ⤷ Try a Trial |
Hungary | T77886 | ⤷ Try a Trial | |
Finland | 84349 | ⤷ Try a Trial | |
China | 1011237 | ⤷ Try a Trial | |
Czech Republic | 9701549 | ⤷ Try a Trial | |
Finland | 119355 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |